Patterned Cell-Scaffold Interactions for Self-Organizing Tissues
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current tissue engineering methods fail to precisely mimic native tissue structures and functions due to ubiquitous cell adhesion across all cell types, which undermines the maintenance of specific tissue architectures.
Innovation Solution
Engineer cells to express or lack specific integrin heterodimers using CRISPR-Cas9, and pattern scaffolds with integrin-specific peptides to allow only targeted cell types to adhere, using polymers like hydrogels for cell placement and organization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If RGD peptide is used for cell adhesion, then cell adhesion is improved, but tissue architecture organization deteriorates due to ubiquitous adhesion across all cell types
Solution Approach 1:
The patent applies local quality by using multiple distinct cell adhesion peptides (e.g., RGD for fibroblasts, YIGSR for neurons, LDV for epithelial cells) patterned at specific locations on the scaffold. Each peptide type creates a localized adhesion zone that selectively binds to its corresponding cell type's integrin receptor, thereby achieving both strong cell adhesion and precise spatial organization of different cell types within the tissue construct.
2Adaptability or versatility
If multiple cell types are cultured on a scaffold, then tissue complexity is improved, but maintaining specific tissue architecture becomes difficult due to non-specific adhesion
Solution Approach 1:
The patent segments the scaffold surface into multiple distinct regions, each functionalized with a specific cell adhesion peptide that attracts and retains a particular cell type. This spatial segmentation allows multiple cell types to coexist on the same scaffold while maintaining their respective organizational patterns, thereby achieving both tissue complexity and architectural precision simultaneously.
3Strength
If cell adhesion motifs are added to scaffolds, then cell adhesion is improved, but control over cell type-specific placement is lost
Solution Approach 1:
The patent implements local quality by assigning different cell adhesion peptide sequences to different spatial locations on the scaffold. Each peptide sequence (such as RGD, YIGSR, LDV, PHSRN) has specificity for particular integrin heterodimers expressed on specific cell types. This localized functional differentiation enables precise control over which cell types adhere to which regions, achieving both strong adhesion and accurate cell type-specific placement.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables self-organizing tissues that maintain structural integrity by confining cells to designated regions, enhancing the complexity and functionality of engineered tissues.
Implementation Method 1
integrin-specific peptides to allow only targeted cell types to adhere
Data Source
AI summary
The present disclosure is directed to scaffold materials patterned with cell adhesion targets that permit the attachment and growth of predetermined cell types onto the scaffold. By selecting specific ligands that are patterned on the scaffold, particular cell types, including those engineered for this specific purpose, will attach and proliferate to create designed tissues and organs.